Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
5.39
+0.39 (7.80%)
At close: Aug 12, 2026, 4:00 PM EDT
5.34
-0.05 (-0.92%)
After-hours: Aug 12, 2026, 5:34 PM EDT
Unicycive Therapeutics Employees
As of December 31, 2025, Unicycive Therapeutics had 22 total employees, including 21 full-time and 1 part-time employees. The number of employees decreased by 1 or -4.35% compared to the previous year.
Employees
22
Change (1Y)
-1
Growth (1Y)
-4.35%
Revenue / Employee
n/a
Profits / Employee
-$1,601,045
Market Cap
147.65M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 22 | -1 | -4.35% | 21 | 1 |
| Dec 31, 2024 | 23 | 9 | 64.29% | 22 | 1 |
| Dec 31, 2023 | 14 | 2 | 16.67% | 14 | 0 |
| Dec 31, 2022 | 12 | 3 | 33.33% | 12 | 0 |
| Dec 31, 2021 | 9 | 8 | 800.00% | 9 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Molecular Partners AG | 134 |
| Cibus | 118 |
| Connect Biopharma Holdings | 64 |
| TuHURA Biosciences | 22 |
| Equillium | 15 |
| Spruce Biosciences | 14 |
| Canton Strategic Holdings | 12 |
| ProMIS Neurosciences | 11 |
UNCY News
- 10 hours ago - Unicycive Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 10 hours ago - Unicycive Therapeutics Quarterly report: Q2 2026 - Filings
- 10 hours ago - Unicycive Therapeutics Earnings release: Q2 2026 - Filings
- 12 days ago - Unicycive Therapeutics Slides: Corporate presentation - Filings
- 6 weeks ago - Unicycive Therapeutics price target lowered to $50 from $60 at Noble Capital - TheFly
- 6 weeks ago - Unicycive Therapeutics price target lowered to $13 from $18 at Benchmark - TheFly
- 6 weeks ago - Johnson Fistel Investigates Unicycive Therapeutics, Inc. (NASDAQ: UNCY) on Behalf of Investors - GlobeNewsWire
- 6 weeks ago - Unicycive Therapeutics price target lowered to $15 from $22 at H.C. Wainwright - TheFly